By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Pew PatriotsPew PatriotsPew Patriots
Notification Show More
Font ResizerAa
  • Home
  • News
  • Tactical
  • Guns and Gear
  • Prepping & Survival
  • Videos
Reading: First GLP-1 pill for weight loss, diabetes shows success in late-phase trial
Share
Font ResizerAa
Pew PatriotsPew Patriots
  • News
  • Tactical
  • Guns and Gear
  • Prepping & Survival
  • Videos
Search
  • Home
  • News
  • Tactical
  • Guns and Gear
  • Prepping & Survival
  • Videos
Have an existing account? Sign In
Follow US
First GLP-1 pill for weight loss, diabetes shows success in late-phase trial
News

First GLP-1 pill for weight loss, diabetes shows success in late-phase trial

Jimmie Dempsey
Last updated: April 17, 2025 8:19 pm
Jimmie Dempsey Published April 17, 2025
Share
SHARE

Injectables for type 2 diabetes and weight loss could soon be a thing of the past.

Eli Lilly announced Thursday the successful completion of a phase 3 trial of Orforglipron – the first small-molecule GLP-1 that is administered as a once-daily oral pill.

The ACHIEVE-1 trial evaluated the efficacy of Orforglipron compared to placebo in adults with type 2 diabetes and “inadequate glycemic control with diet and exercise alone.”

FAKE OZEMPIC DRUGS FOUND IN US DRUG SUPPLY, FDA WARNS

The results showed lowered A1C (blood sugar) in patients by an average of 1.3% to 1.6% across doses, according to a press release.

More than 65% of participants taking the highest dose of the drug scored an A1C less than or equal to 6.5%, which is below the defined threshold for diabetes, according to the American Diabetes Association.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Trial participants also saw reduced weight by an average of 16 pounds, or 7.9%, at the highest dose.

Participants had not reached a weight plateau when the study ended, which suggests there was still weight to be lost, according to the researchers.

Eli Lilly

The trial also found that the overall safety and tolerability of the drug was consistent with the classic injectable GLP-1s, like Ozempic, Wegovy, Mounjaro and Zepbound.

If Orforglipron achieves approval by the U.S. Food and Drug Administration, Eli Lilly projected its confidence in launching the drug “worldwide without supply constraints.”

For more Health articles, visit www.foxnews.com/health

“This would further Lilly’s mission to reduce chronic diseases like type 2 diabetes, which is expected to impact an estimated 760 million adults by 2050,” the pharmaceutical company wrote in its announcement.

GLP-1 syringe

David A. Ricks, Eli Lilly chair and CEO, commented in a statement, “We are pleased to see that our latest incretin medicine meets our expectations for safety and tolerability, glucose control and weight loss, and we look forward to additional data readouts later this year.”

“As a convenient once-daily pill, Orforglipron may provide a new option and, if approved, could be readily manufactured and launched at scale for use by people around the world.”

  

Eli Lilly intends to submit Orforglipron for weight management to global regulatory agencies by the end of 2025, as well as for type 2 diabetes treatment in 2026, according to the company.

Read the full article here

You Might Also Like

DC food workers vow Trump officials won’t feel welcomed when dining out in nation’s capital

Nets ‘thank’ player who never appeared in a game for them this season amid roster move

Trump’s DOGE stays on track after pair of federal judge rulings

Shiloh Sharps 1874 Sporter # 1

Trump warns FEMA faces a reckoning after Biden admin: ‘Not done their job’

Share This Article
Facebook Twitter Email Print
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

We Recommend
Veteran advocacy leader defends Trump’s shake-ups at VA, calls for reform to support veterans
News

Veteran advocacy leader defends Trump’s shake-ups at VA, calls for reform to support veterans

Jimmie Dempsey Jimmie Dempsey May 9, 2025
The Classics: Colt New Model Army Revolver of 1860
Felon hid dead uncle in trash can to keep stealing his vets benefits
Hands-On with the Dead Air Sandman S
Pakistan Says It Killed Up To 50 Indian Soldiers In Fresh Border Clashes
Psaki bombs: MSNBC’s newest primetime program sheds 53% of viewers from key demo in second episode
Newsom debuts rapid-response website as critics accuse him of prioritizing presidential ambitions
News

Newsom debuts rapid-response website as critics accuse him of prioritizing presidential ambitions

Jimmie Dempsey Jimmie Dempsey May 9, 2025
Jemele Hill returns to ESPN’s ‘Around the Horn’ before show’s cancellation, jokes about previous firing
News

Jemele Hill returns to ESPN’s ‘Around the Horn’ before show’s cancellation, jokes about previous firing

Jimmie Dempsey Jimmie Dempsey May 9, 2025
USA Fencing transgender controversy escalates at DOGE hearing with social media regrets, calls for resignation
News

USA Fencing transgender controversy escalates at DOGE hearing with social media regrets, calls for resignation

Jimmie Dempsey Jimmie Dempsey May 9, 2025
Pew Patriots
  • News
  • Tactical
  • Prepping & Survival
  • Guns and Gear
  • Videos
  • Blog
2024 © Pew Patriots. All Rights Reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?